Crossmark

Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis

Crossref DOI link: https://doi.org/10.1186/s12933-024-02424-7

Published Online: 2024-09-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Chung-An

Lin, Li-Chun

Chen, Jui-Yi

Wang, Wei-Jie

Wu, Vin-Cent
License Information

Text and Data Mining valid from 2024-09-03

Version of Record valid from 2024-09-03
More Information

Article History

Received: 24 June 2024

Accepted: 27 August 2024

First Online: 3 September 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below